NEWS & MEDIA

17/09/2019
Market announcement – IQN acquires interest in a new anticancer drug platform from University of Texas

06/06/2018
IQN Market update of iQnovate Ltd Subsidiary Life Science Biosensor Diagnostics Pty Ltd

27/10/2017
Notice of iQnovate 2017 AGM

20/10/2017
iQnovate Ltd 2017 Annual Report

05/10/2017
iQN License Agreement MENA Announcement

05/07/2017
Extension of proposed Convertible Note Issue

19/03/2015
iQ Group Founder and CEO featured in April issue of CEO Magazine

13/05/2014
Siberian Adventure Benefits Childrens Charity

27/09/2013
[IQN] Preliminary Final Report (Price Sensitive)

12/09/2013
[IQN] Approval to Commence Trading on GXG

27/08/2013
[IQN] Nominated Advisers Annual Statement to NSX

01/08/2013
[IQN] Listing on GXG Europe

13/06/2013
[IQN] IQNovate ADRs Piggyback Qualified in the USA

07/06/2013
[IQN] Response to Price Query – trade executed 5th of June 2013

07/06/2013
[IQN] Price Query – trades executed on the 5th of June 2013

05/06/2013
[IQN] Response to Price Query – trade executed 4th of June 2013

05/06/2013
[IQN] Price Query – trade executed on the 4th of June 2013

23/05/2013
[IQN] US Media Coverage

12/05/2013
[IQN] IQNovate Ltd Receives Quotation Clearance for OTC Pink

22/03/2013
[IQN] Change of Nominated Advisor

15/03/2013
[IQN] Half Yearly Financial Statements – 31 December 2012

13/03/2013
[IQN] Private Placement Issue and Release of 1 year Escrow

12/03/2013
[IQN] Closure of Private Placement

18/12/2012
[IQN] IQNovate Ltd included in Mergent’s manual in the USA

17/12/2012
[IQN] IQN Begins Trading in US thorugh Launch of ADRS

30/11/2012
[IQN] Results of 2012 AGM

28/11/2012
[IQN] Updated Constitution

28/11/2012
[IQN] Change in Director’s Interests – G Syrmalis

28/11/2012
[IQN] Change in Director’s Interests – G Syrmalis

22/11/2012
[IQN] Response from Issuer to Price Query dated 20th of November 2012

22/11/2012
[IQN] Price Query for trades executed on the 20th of November 2012

30/10/2012
[IQN] IQNovate to undertake private share placement

29/10/2012
[IQN] 2012 IQNovate Ltd Annual Report

29/10/2012
[IQN] Notice of 2012 Annual General Meeting

29/10/2012
[IQN] IQNovate signs agreement with Connect Biotech Pvte Ltd in India (Price Sensitive)

03/10/2012
[IQN] Removal of requested trading halt.

03/10/2012
[IQN] Iqnovate seeking to list on OTC Pink Marketplace in USA (Price Sensitive)

02/10/2012
[IQN] Withdrawal of Application for Listing on ASX (Price Sensitive)

02/10/2012
[IQN] Iqnovate Ltd Requests Trading Halt (Price Sensitive)

27/09/2012
[IQN] Statutory Financial Accounts as required by Corporations Act (Price Sensitive)

17/09/2012
[IQN] Response to Price Query – 13th of September 2012

17/09/2012
[IQN] Price query for trade executed from 13th of September 2012

13/09/2012
[IQN] Prelinimary Final Report – 30 June 2012 (Price Sensitive)

13/08/2012
[IQN] Nominated Advisers Annual Statement to NSX

03/08/2012
[IQN] Update on Move To ASX

26/06/2012
[IQN] Passing of Resolution at Extraordinary General Meeting

14/06/2012
[IQN] IQNovate Limited Signs Technical Services Agreement

14/05/2012
[IQN] Notice of Extraordinary General Meeting

02/05/2012
[IQN] IQnovate Signs Memorandum of Understanding with Nanosonics (Price Sensitive)

02/05/2012
[IQN] Share placement

30/03/2012
[IQN] IQnovate Seeks to Move to ASX (Price Sensitive)

30/03/2012
[IQN] IQnovate Share Placement Completion (Price Sensitive)

14/03/2012
[IQN] IQnovate Signs Memorandum of Understanding (Price Sensitive)

13/03/2012
[IQN] Half Year Report (Price Sensitive)

08/03/2012
[IQN] IQnovate to Undertake Share Placement (Price Sensitive)

22/02/2012
[IQN] Appointment of Business Development Manager and Move of Headquarters to CBD

30/01/2012
[IQN] Change in Director’s Interests – C Tisgounis

27/01/2012
[IQN] Response to Price Query.